Skip to Content

WPI 2245 (Mesalamine Delayed-Release 1.2 g)

Pill with imprint WPI 2245 is Brown, Elliptical / Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Actavis Pharma, Inc..

Mesalamine is used in the treatment of ulcerative colitis, maintenance; crohn's disease, maintenance; ulcerative colitis; ulcerative colitis, active; ulcerative proctitis (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2245

Mesalamine Delayed-Release

Imprint:
WPI 2245
Strength:
1.2 g
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
5-aminosalicylates
Pregnancy Category:
B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2245

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide